Quality by Design (QbD) in Pharmaceutical Manufacturing | QTPP, CQA, CMA, CPP & Control Strategy
Pharmatalks
0:00 / 0:00
Quality by Design (QbD) in Pharmaceutical Manufacturing | QTPP, CQA, CMA, CPP & Control Strategy
177 просмотров · 3 недели назад
Pharmatalks
11,6 тыс. подписчиков
177 просмотров · 3 недели назад
What does Quality by Design (QbD) really mean in pharmaceutical manufacturing?
In this complete Pharmatalks guide, we take you step by step through the QbD lifecycle — from defining the Quality Target Product Profile (QTPP) to identifying CQAs, CMAs, and CPPs, performing risk assessment, using DOE, and finally building an effective control strategy.
You’ll learn how pharmaceutical quality can be built into the product and manufacturing process instead of relying only on end-product testing.
What You’ll Learn
Quality by Design fundamentals
QTPP and product quality targets
Critical Quality Attributes — CQAs
Critical Material Attributes — CMAs
Critical Process Parameters — CPPs
CMA–CQA and CPP–CQA relationships
Pharmaceutical risk assessment
FMEA and risk matrices
Process understanding
Design of Experiments — DOE
Interaction effects
Control strategy
Process Analytical Technology — PAT
Real-time process monitoring
Scale-up using QbD
Continued Process Verification — CPV
Continuous improvement and lifecycle management
Chapters / Timeline
00:00 — QbD Fundamentals & Lifecycle
Slides 1–10: What is QbD, traditional quality vs QbD, QbD mindset, patient needs, and lifecycle thinking.
04:59 — QTPP & Critical Quality Attributes
Slides 11–20: QTPP, CQAs, tablet quality attributes, dissolution, impurities, and CQA risk ranking.
10:11 — CMAs & Critical Process Parameters
Slides 21–30: Material attributes, API particle size, excipient variability, CPPs, granulation, and tablet compression.
15:27 — Risk Assessment, FMEA & DOE
Slides 31–40: Risk assessment, risk scoring, FMEA, Ishikawa analysis, knowledge management, process understanding, DOE, and interaction effects.
20:48 — Control Strategy & Lifecycle Improvement
Slides 41–50: Control strategy, PAT, real-time monitoring, scale-up, continued process verification, regulatory value, and continuous improvement.
Who Should Watch?
This video is useful for:
Pharmaceutical QA professionals
QC analysts
Validation specialists
Formulation and R&D scientists
Process engineers
Production professionals
Regulatory Affairs teams
Pharmaceutical students
Anyone preparing for pharma technical interviews
Follow Pharmatalks for practical videos on pharmaceutical manufacturing, GMP, validation, quality systems, HPLC, cleanrooms, and pharmaceutical career development.
#QualityByDesign #QbD #PharmaceuticalManufacturing #Pharma #GMP #QTPP #CQA #CMA #CPP #ProcessValidation #QualityAssurance #PharmaceuticalQuality #RiskAssessment #FMEA #DOE #PAT #Pharmatalks